BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32003052)

  • 1. Dynamic
    Dehghani M; Zhang S; Kumaragamage C; Rosa-Neto P; Near J
    Magn Reson Med; 2020 Sep; 84(3):1140-1151. PubMed ID: 32003052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective proton-observed, carbon-edited (selPOCE) MRS method for measurement of glutamate and glutamine
    De Feyter HM; Herzog RI; Steensma BR; Klomp DWJ; Brown PB; Mason GF; Rothman DL; de Graaf RA
    Magn Reson Med; 2018 Jul; 80(1):11-20. PubMed ID: 29134686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRESS timings for resolving
    Dobberthien BJ; Tessier AG; Stanislaus AE; Sawyer MB; Fallone BG; Yahya A
    NMR Biomed; 2019 Dec; 32(12):e4180. PubMed ID: 31518031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive 3-Dimensional 1 H-Magnetic Resonance Spectroscopic Imaging of Human Brain Glucose and Neurotransmitter Metabolism Using Deuterium Labeling at 3T : Feasibility and Interscanner Reproducibility.
    Niess F; Hingerl L; Strasser B; Bednarik P; Goranovic D; Niess E; Hangel G; Krššák M; Spurny-Dworak B; Scherer T; Lanzenberger R; Bogner W
    Invest Radiol; 2023 Jun; 58(6):431-437. PubMed ID: 36735486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR measurement of brain oxidative metabolism in monkeys using 13C-labeled glucose without a 13C radiofrequency channel.
    Boumezbeur F; Besret L; Valette J; Vaufrey F; Henry PG; Slavov V; Giacomini E; Hantraye P; Bloch G; Lebon V
    Magn Reson Med; 2004 Jul; 52(1):33-40. PubMed ID: 15236364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel strategy for cerebral 13C MRS using very low RF power for proton decoupling.
    Li S; Yang J; Shen J
    Magn Reson Med; 2007 Feb; 57(2):265-71. PubMed ID: 17260369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect
    Jacobs SM; Prompers JJ; van der Kemp WJM; van der Velden TA; Gosselink M; Meliadò EF; Hoogduin HM; Mason GF; de Graaf RA; Miller CO; Bredael GM; van der Kolk AG; Alborahal C; Klomp DWJ; Wiegers EC
    NMR Biomed; 2024 Jun; ():e5195. PubMed ID: 38845018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved resolution of glutamate, glutamine and γ-aminobutyric acid with optimized point-resolved spectroscopy sequence timings for their simultaneous quantification at 9.4 T.
    Dobberthien BJ; Tessier AG; Yahya A
    NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29105187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo quantification of neuro-glial metabolism and glial glutamate concentration using 1H-[13C] MRS at 14.1T.
    Lanz B; Xin L; Millet P; Gruetter R
    J Neurochem; 2014 Jan; 128(1):125-39. PubMed ID: 24117599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective resonance suppression 1H-[13C] NMR spectroscopy with asymmetric adiabatic RF pulses.
    Xin L; Frenkel H; Mlynárik V; Morgenthaler FD; Gruetter R
    Magn Reson Med; 2009 Feb; 61(2):260-6. PubMed ID: 19165882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized 13C NMR spectroscopy in the human brain of amino acid labeling from D-[1-13C]glucose.
    Gruetter R; Novotny EJ; Boulware SD; Mason GF; Rothman DL; Shulman GI; Prichard JW; Shulman RG
    J Neurochem; 1994 Oct; 63(4):1377-85. PubMed ID: 7931289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo proton observed carbon edited (POCE)
    Kumaragamage C; Madularu D; Mathieu AP; De Feyter H; Rajah MN; Near J
    Magn Reson Med; 2018 Feb; 79(2):628-635. PubMed ID: 28497464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.
    Lin AP; Shic F; Enriquez C; Ross BD
    MAGMA; 2003 Feb; 16(1):29-42. PubMed ID: 12695884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of glutamate, glutamine, and glutathione by radiofrequency suppression and echo time optimization at 7 tesla.
    An L; Li S; Murdoch JB; Araneta MF; Johnson C; Shen J
    Magn Reson Med; 2015 Feb; 73(2):451-8. PubMed ID: 24585452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimum echo time PRESS-based proton observed carbon edited (POCE) MRS in rat brain using simultaneous editing and localization pulses.
    Kumaragamage C; Madularu D; Mathieu AP; Lupinsky D; de Graaf RA; Near J
    Magn Reson Med; 2018 Oct; 80(4):1279-1288. PubMed ID: 29427395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
    Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
    Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Field
    Li N; Li S; Shen J
    Front Phys; 2017; 5():. PubMed ID: 29177139
    [No Abstract]   [Full Text] [Related]  

  • 18. Glutamate metabolism in epilepsy: 13C-magnetic resonance spectroscopy observation in the human brain.
    Otsuki T; Nakama H; Kanamatsu T; Tsukada Y
    Neuroreport; 2005 Dec; 16(18):2057-60. PubMed ID: 16317354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo
    Lai M; Lanz B; Poitry-Yamate C; Romero JF; Berset CM; Cudalbu C; Gruetter R
    J Cereb Blood Flow Metab; 2018 Oct; 38(10):1701-1714. PubMed ID: 29047296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of in vivo MRS measures of metabolite concentrations in the human brain.
    Dhamala E; Abdelkefi I; Nguyen M; Hennessy TJ; Nadeau H; Near J
    NMR Biomed; 2019 Mar; 32(3):e4058. PubMed ID: 30663818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.